Accession Number : ADB126086
Title : Research in Drug Development against Viral Diseases of Military Importance (Biological Testing).
Descriptive Note : Annual rept. 15 Nov 86-14 Nov 87,
Corporate Author : SOUTHERN RESEARCH INST BIRMINGHAM AL
Personal Author(s) : Shannon, W. M. ; Holland, L. E. ; Arnett, G. ; Brando, L. V. ; Brazier, A. D.
Report Date : 15 DEC 1987
Pagination or Media Count : 385
Abstract : The purpose of this program is to evaluate the efficacy of candidate antiviral compounds against a spectrum of viruses of military importance. This program involves (a) primary testing of chemical compounds and natural products for antiviral efficacy in vitro using CPE-inhibition and plaque-reduction assays, (b) primary testing of compounds for antiviral efficacy in vivo in animal model systems, and (c) secondary evaluation of the active candidate antiviral compounds. The target viruses for invitro testing are Vaccinia Virus (VV), Adenovirus (AD), Vesicular Stomatitis Virus (VSV), Punta Toro Virus (PT), Sandfly Fever Virus (SF), Yellow Fever Virus (YF), Venezuelan Equine Encephalomyelitis Virus (VEE), Japanese Encephalitis Virus (JE), Pichinde Virus (PIC), Hantaan Virus (HTN), Human Immunodeficiency Virus (HIV), and related murine, feline, and simian retroviruses. The current in vivo systems are Pichinde Virus infection of hamsters and Venezuelan Equine Encephalomyelitis Virus infection of mice. During this second year of the project all in vitro and in vivo screening systems became operational. Antiviral drugs, RNA Viruses, AIDS. (AW/MJM)
Descriptors : *ANTIVIRAL AGENTS, ADENOVIRUSES, ANIMALS, BIOLOGY, CHEMICAL COMPOUNDS, DRUGS, EFFICIENCY, HAMSTERS, IN VITRO ANALYSIS, IN VIVO ANALYSIS, JAPANESE ENCEPHALITIS VIRUSES, MICE, MODELS, NATURAL RESOURCES, RIBONUCLEIC ACIDS, SANDFLY FEVER VIRUS INFECTION, SECONDARY, SPECTRA, TEST AND EVALUATION, VACCINIA VIRUS, VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS, VESICULAR STOMATITIS, VIRUS DISEASES, VIRUSES, YELLOW FEVER VIRUS.
Subject Categories : Pharmacology
Distribution Statement : APPROVED FOR PUBLIC RELEASE